Vivos Therapeutics, Inc. (VVOS) Stock

Vivos Therapeutics, Inc., a pioneering medical technology company headquartered in Littleton, Colorado, specializes in developing and commercializing innovative treatments for patients suffering from dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. At the forefront of its offerings is The Vivos Method, a non-invasive, non-surgical, and non-pharmaceutical treatment approach that integrates various disciplines to address these conditions effectively. This method not only aims to correct dentofacial issues but also targets OSA and snoring, providing patients with comprehensive therapeutic solutions.

In addition to The Vivos Method, the company provides the VivoScore Program, which includes screening tools and home sleep tests for both adults and children. By offering these diagnostic services, Vivos Therapeutics, Inc. enhances the accessibility and accuracy of sleep disorder assessments, supporting healthcare professionals in delivering tailored treatment plans. The company's appliances and related treatments are marketed and sold primarily to licensed professionals, particularly general dentists across the United States and Canada, expanding its reach and impact in the field of sleep medicine.

Founded in 2016, Vivos Therapeutics, Inc. continues to advance its mission of improving patient outcomes through innovative healthcare solutions. With a commitment to technological innovation and clinical excellence, the company remains dedicated to transforming the landscape of dentofacial and sleep disorder treatments, ultimately enhancing the quality of life for individuals affected by these conditions.